{'terms': u'%28myasthenia%5btitle%5d+and+gravis%5btitle%5d%29+and+%28%22loattrfree+full+text%22%5bsb%5d+and+%221998%2f09%2f22%22%5bedat%5d+%3a+%222008%2f09%2f18%22%5bedat%5d+and+%222003%2f09%2f21%22%5bpdat%5d+%3a+%222008%2f09%2f18%22%5bpdat%5d+and+%22humans%22%5bmesh+terms%5d+and+english%5blang%5d+and+%28clinical+trial%5bptyp%5d+or+editorial%5bptyp%5d+or+letter%5bptyp%5d+or+meta%2danalysis%5bptyp%5d+or+practice+guideline%5bptyp%5d+or+randomized+controlled+trial%5bptyp%5d+or+review%5bptyp%5d%29%29', 'desc': 'Myasthenia gravis is a chronic autoimmune neuromuscular disease. It is characterized by varying degrees of weakness of the skeletal muscles of the body. Common symptoms include weakness of the muscles that control the eye and eyelid, facial expression, chewing, talking, and swallowing. Weakness tends to increase during periods of activity and improves after periods of rest.', 'db': u'pubmed', 'syn': [], 'uid': ''}